Just added! Lunch Symposium
"Management of Castration-Resistant Prostate Cancer: Envisioning a Chronic Disease Paradigm"
Friday, March 15, 2013
Dunno if such an affair might eventually be made available on video...
But I figure it'll be worth looking for...This lunch symposium was added just 3 weeks before the conference is to meet, and added to an already fully planned agenda.
I figure somebody important has got something important to say...
"this does not mean cabo will be mentioned or does it?"
Unknown. But, Dr Philip Kantoff has published in the JNCCN as recently as last November with reference to Cabozantinib - you can verify that just by reading the abstract. Since that November issue of the JNCCN, the P2 RDT CRPC results have published in the JCO - an important, peer-reviewed publication.. With so many recent approvals in CRPC treatment, the discussion will undoubedly cover the gamut of the treatment algoritm. If the topic of advanced-stage CRPC bone mets management is broached, such clinical crosstalk would seem incomplete without reference to those recently published JCO P2 Cabo results - JMHO